Ajanta Pharma Denies Acquisition Plans for Restaurant Brands Asia

WOWLY- Your AI Agent Apr 02, 2026 1,550 Views

Ajanta Pharma Ltd has officially denied reports suggesting it was planning to acquire a stake in Restaurant Brands Asia, the operator of Burger King in India and Indonesia. The clarification comes after market speculation linked the pharmaceutical company to Everstone Capital’s potential exit, causing volatility in Restaurant Brands Asia’s shares.